- Home
- KNSA vs WEN Comparison
KNSA vs WEN Comparison
Compare KNSA & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- WEN
- Stock Information
- Founded
- KNSA 2015
- WEN 1969
- Country
- KNSA United Kingdom
- WEN United States
- Employees
- KNSA N/A
- WEN 14500
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- WEN Restaurants
- Sector
- KNSA Health Care
- WEN Consumer Discretionary
- Exchange
- KNSA Nasdaq
- WEN Nasdaq
- Market Cap
- KNSA 1.9B
- WEN 2.1B
- IPO Year
- KNSA 2018
- WEN N/A
- Fundamental
- Price
- KNSA $28.44
- WEN $12.01
- Analyst Decision
- KNSA Strong Buy
- WEN Hold
- Analyst Count
- KNSA 5
- WEN 17
- Target Price
- KNSA $38.80
- WEN $16.38
- AVG Volume (30 Days)
- KNSA 707.0K
- WEN 5.8M
- Earning Date
- KNSA 07-22-2025
- WEN 07-31-2025
- Dividend Yield
- KNSA N/A
- WEN 7.45%
- EPS Growth
- KNSA N/A
- WEN N/A
- EPS
- KNSA N/A
- WEN 0.94
- Revenue
- KNSA $481,166,000.00
- WEN $2,235,211,000.00
- Revenue This Year
- KNSA $37.21
- WEN N/A
- Revenue Next Year
- KNSA $5.32
- WEN $4.14
- P/E Ratio
- KNSA N/A
- WEN $12.69
- Revenue Growth
- KNSA 59.45
- WEN 2.18
- 52 Week Low
- KNSA $17.38
- WEN $10.91
- 52 Week High
- KNSA $30.69
- WEN $20.60
- Technical
- Relative Strength Index (RSI)
- KNSA 55.24
- WEN 56.57
- Support Level
- KNSA $27.62
- WEN $10.91
- Resistance Level
- KNSA $28.69
- WEN $11.58
- Average True Range (ATR)
- KNSA 1.13
- WEN 0.36
- MACD
- KNSA -0.28
- WEN 0.07
- Stochastic Oscillator
- KNSA 45.78
- WEN 97.35
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About WEN Wendy's Company (The)
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.6 billion in 2024, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($51.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned more than 7,200 total stores in 30 countries as of year-end 2024. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for roughly 94% of stores, and through franchise flipping and advisory fees.